| (Values in U.S. Thousands) | Feb, 2023 | Nov, 2022 | Aug, 2022 | Feb, 2022 | Nov, 2021 |
| Sales | -22 | 18 | 39 | 40 | 48 |
| Sales Growth | -225.97% | -54.32% | -2.62% | -18.41% | -71.64% |
| Net Income | -413 | -1,031 | -468 | -1,444 | -418 |
| Net Income Growth | +59.97% | -120.34% | +67.61% | -245.25% | +65.79% |
Canntab Therapeutics Ltd (PILL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Canntab Therapeutics Ltd is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of pharmaceutical-grade formulations of cannabinoids. It has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use.
Fiscal Year End Date: 05/31